Blue Vault
About the Company
Blue Vault provides its subscribers with the factual performance metrics, from beginning to end, needed to make better informed decisions concerning nontraded REITs, BDCs, and Closed-End Funds, Interval Funds and Private Offerings. Knowledge is power, in this case, the power to be completely informed before deciding on which alternative investments to use and the power to protect your practice from misleading sales and marketing tactics. Don’t be partially informed ever again. Utilize our expertise and solid research data services to know the facts.
“Blue Vault’s mission is to conduct and provide reliable and thorough nontraded REIT and BDC performance-based research. Our top priority is helping keep you informed. Our commitment to you is transparency and education.”
Founded
2009
Founders
Stacy Chitty
Vee Kimbrell
Management Team
Stacy Chitty: Managing Partner
Jim Sprow: Senior Vice President, Research
Betsy Ricks: Vice President, Business Development
News, Announcements, and More…
KBRA Releases Research – Second-Quarter 2023 Business Development Company (BDC) Ratings Compendium
KBRA releases its Business Development Company Ratings Compendium, which looks at results for the quarter ended June 30, 2023, and offers a review of perpetual continuously offered non-traded BDCs as well as recent industry developments….
ExchangeRight Achieves 133.18% to 142.47% Total Returns Including Return of Capital with 33rd Full-Cycle Offering
ExchangeRight, one of the nation’s leading providers of diversified real estate DST and REIT investments, has announced that the company has successfully brought its 33rd offering full cycle on behalf of investors. Net-Leased Portfolio 22 DST, a diversified portfolio of 15 properties net-leased to historically recession-resilient tenants, was acquired by ExchangeRight’s Essential Income REIT after a five-year hold period. ExchangeRight provided investors multiple exit options at their sole discretion upon closing, with total net annual returns to investors ranging from 6.37% to 8.29%…
NexPoint Announces Co-investment in NexPoint Life Sciences II DST
NexPoint, a multibillion-dollar alternative investment platform, announces it has made an initial investment in NexPoint Life Sciences II DST, a Delaware statutory trust (DST), through a fund advised by its affiliate. The investment represents 6% of the total equity available. NexPoint plans to increase the investment size, ultimately targeting 10%-12% of the total equity available…
Strategic Partnerships
SmartStop Asset Management
CIM Group
Services
Data
Education
Consulting
